参考文献/References:
[1] 周凯华,石兴民. 不同程度肝纤维化患者 IGF-2及 IGFBP-2与 MMPs 家族相关性分析[J].陕西医学杂志,2015,44(8):972-974.
[2] 李福广,徐 军. 姜黄素对原发性肝癌组织中肝星状细胞活性影响的实验研究[J].陕西医学杂志,2016,45(6):649-651,712.
[3] Lin X,Kong LN,Huang C,et al. Hesperetin derivative-7 inhibits PDGF-BB-induced hepatic stellate cell activation and proliferation by targeting Wnt/beta-catenin pathway[J]. Int Immunopharmacol,2015,25(2):311-320.
[4] He Y,Huang C,Sun X,et al. MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4[J]. Cell Signal,2012,24(10):1923-1930.
[5] Presser LD,Mcrae S,Waris G. Activation of TGF-beta1 promoter by hepatitis C virus-induced AP-1 and Sp1:role of TGF-beta1 in hepatic stellate cell activation and invasion[J]. PLoS One,2013,8(2):e56367.
[6] Hou Q,Lin J,Huang W,et al. CTRP3 Stimulates proliferation and anti-apoptosis of prostate cells through PKC signaling pathways[J]. PLoS One,2015,10(7):e134006.
[7] Petersen PS,Wolf RM,Lei X,et al. Immunomodulatory roles of CTRP3 in endotoxemia and metabolic stress[J]. Physiol Rep,2016,4(5):577-581.
[8] Murayama MA,Kakuta S,Maruhashi T,et al. CTRP3 plays an important role in the development of collagen-induced arthritis in mice[J]. Biochem Biophys Res Commun,2014,443(1):42-48.
[9] Wolf RM,Lei X,Yang ZC,et al. CTRP3 deficiency reduces liver size and alters IL-6 and TGFbeta levels in obese mice[J]. Am J Physiol Endocrinol Metab,2016,310(5):E332-E345.
[10] Lei X,Li Q,Rodriguez S,et al. Thromboxane synthase deficiency improves insulin action and attenuates adipose tissue fibrosis[J]. Am J Physiol Endocrinol Metab,2015,308(9):E792-E804.
[11] Wu D,Lei H,Wang JY,et al. CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation[J]. J Mol Med(Berl),2015,93(12):1311-1325.
[12] Qi F,Hu JF,Liu BH,et al. MiR-9a-5p regulates proliferation and migration of hepatic stellate cells under pressure through inhibition of Sirt1[J]. World J Gastroenterol,2015,21(34):9900-9915.
[13] Wang FP,Li L,Li J,et al. High mobility group box-1 promotes the proliferation and migration of hepatic stellate cells via TLR4-dependent signal pathways of PI3K/Akt and JNK[J]. PLoS One,2013,8(5):e64373.
[14] Li FB,Zhao H,Peng KR,et al. Expression of transforming growth factor-beta1 and connective tissue growth factor in congenital biliary atresia and neonatal hepatitis liver tissue[J]. Genet Mol Res,2016,15(1):894-899.
[15] Liu Y,Brymora J,Zhang H,et al. Leptin and acetaldehyde synergistically promotes alphaSMA expression in hepatic stellate cells by an interleukin 6-dependent mechanism[J]. Alcohol Clin Exp Res,2011,35(5):921-928.
[16] Balta C,Herman H,Boldura OM,et al. Chrysin attenuates liver fibrosis and hepatic stellate cell activation through TGF-beta/smad signaling pathway[J]. Chem Biol Interact,2015,240:94-101.
[17] Qu Y,Zong L,Xu M,et al. Effects of 18alpha-glycyrrhizin on TGF-beta1/Smad signaling pathway in rats with carbon tetrachloride-induced liver fibrosis[J]. Int J Clin Exp Pathol,2015,8(2):1292-1301.
[18] Fang L,Huang C,Meng X,et al. TGF-beta1-elevated TRPM7 channel regulates collagen expression in hepatic stellate cells via TGF-beta1/Smad pathway[J]. Toxicol Appl Pharmacol,2014,280(2):335-344.
[19] Yoshida K,Matsuzaki K. Differential regulation of TGF-beta/Smad signaling in hepatic stellate cells between acute and chronic liver injuries[J]. Front Physiol,2012,3:53.
[20] Latella G,Vetuschi A,Sferra R,et al. Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice[J]. Liver Int,2009,29(7):997-1009.
[21] Xu F,Liu C,Zhou D,et al. TGF-beta/Smad pathway and its regulation in hepatic Fibrosis[J]. J Histochem Cytochem,2016,64(3):157-167.
相似文献/References:
[1]蔡碧莲,文亦磊△,罗伟生△.大鼠肝纤维化实验动物模型的构建*[J].陕西医学杂志,2020,49(6):659.[doi:DOI:10.3969/j.issn.10007377.2020.06.005]
[2]刘翔宇,王凌云.环杷明抑制肝星形细胞激活改善肝纤维化作用实验研究*[J].陕西医学杂志,2020,49(6):663.[doi:DOI:10.3969/j.issn.10007377.2020.06.006]
LIU Xiangyu,WANG Lingyun..Effect of cyclopamine on inhibiting the activation of hepatic astrocyte and improving hepatic fibrosis[J].,2020,49(5):663.[doi:DOI:10.3969/j.issn.10007377.2020.06.006]
[3]韩艳珍,单铁英,李 伟,等.口服枸杞多糖对小鼠肝纤维化组织基质金属蛋白酶-2及基质金属蛋白酶-2抑制剂水平影响的实验研究[J].陕西医学杂志,2021,50(3):276.[doi:DOI:10.3969/j.issn.1000-7377.2021.03.005]
HAN Yanzhen,SHAN Tieying,LI Wei,et al.Effects of Lycium barbarum polysaccharide on the levels of MMP-2 and TIMP-2 in mice with liver fibrosis[J].,2021,50(5):276.[doi:DOI:10.3969/j.issn.1000-7377.2021.03.005]
[4]姜 帆,李春香,李忠原.超声双模态影像技术联合动态增强磁共振检查对大鼠早期肝纤维化的评估价值实验研究[J].陕西医学杂志,2023,52(3):273.[doi:DOI:10.3969/j.issn.1000-7377.2023.03.006]
JIANG Fan,LI Chunxiang,LI Zhongyuan.Evaluation value of ultrasound dual-modality imaging technique combined with DCE-MRI in rats with early hepatic fibrosis[J].,2023,52(5):273.[doi:DOI:10.3969/j.issn.1000-7377.2023.03.006]
[5]郝礼森,潘恩亮,季景秀,等.含SH2结构域蛋白酪氨酸磷酸酶2表达变化对肝纤维化大鼠肝组织中细胞外信号调节激酶1/2活性的影响[J].陕西医学杂志,2023,52(12):1642.[doi:DOI:10.3969/j.issn.1000-7377.2023.12.004]
HAO Lisen,PAN Enliang,JI Jingxiu,et al.Effects of SHP2 expression changes on ERK1/2 activity in liver tissues of rats with hepatic fibrosis[J].,2023,52(5):1642.[doi:DOI:10.3969/j.issn.1000-7377.2023.12.004]
[6]艾丁丁,罗伟生△,蒋云霞.动物肝纤维化模型建立研究进展*[J].陕西医学杂志,2020,49(7):907.[doi:DOI:10.3969/j.issn.10007377.2020.07.038]
AI Dingding,LUO Weisheng,JIANG Yunxia..Progress in the establisment of animal liver fibrosis model[J].,2020,49(5):907.[doi:DOI:10.3969/j.issn.10007377.2020.07.038]
[7]刘 俊,曾 龙,高 云,等.长链非编码RNA YAF2-AS1通过调控微小RNA-141-3p表达抑制肝星状细胞活化实验研究[J].陕西医学杂志,2023,52(9):1120.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.002]
LIU Jun,ZENG Long,GAO Yun,et al.Long-chain non-coding RNA YAF2-AS1 inhibits activation of hepatic stellate cells by regulating expression of microRNA-141-3p[J].,2023,52(5):1120.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.002]